AGP Limited has announced a strong financial performance for the quarter ended March 31, 2026, reporting healthy growth in both revenue and profitability, reflecting continued demand for its pharmaceutical products and operational efficiency.
According to the company’s unconsolidated financial results, net revenue from contracts with customers increased to Rs. 5.39 billion, compared with Rs. 4.81 billion recorded in the corresponding quarter last year. The improvement in sales helped lift gross profit to Rs. 2.49 billion, up from Rs. 2.18 billion in the same period of 2025.
AGP posted a net profit of Rs. 556.9 million for the quarter, representing an increase of nearly 20% from Rs. 465.7 million reported a year earlier. As a result, earnings per share (EPS) improved to Rs. 1.99, compared with Rs. 1.66 in the corresponding period last year.
The company also reported profit before taxation of Rs. 922.3 million, supported by higher sales despite increased marketing, selling, and administrative expenses. AGP continued to invest in strengthening its commercial operations while maintaining profitability.
On the balance sheet, AGP’s total assets increased to approximately Rs. 21.84 billion as of March 31, 2026, compared with Rs. 20.44 billion at the end of December 2025, reflecting continued business expansion and investment in operations. Shareholders’ equity also strengthened during the quarter, supported by higher retained earnings.
The Board of Directors, in its meeting held on April 29, 2026, did not recommend any cash dividend, bonus shares, or right shares for the period. However, the board approved several strategic initiatives aimed at expanding AGP’s product portfolio and growth prospects. These include evaluating potential acquisitions and investments, undertaking contract marketing for Xanax and Viagra, and securing the marketing and distribution rights for STADA’s Oilatum product range in Pakistan.
The latest quarterly performance highlights AGP’s continued momentum in Pakistan’s pharmaceutical sector, with rising revenues, improving profitability, and strategic expansion initiatives positioning the company for sustained long-term growth.
